Prefilled Syringes Market

Publisher Roots Analysis

Published Feb 01, 2024

Length 867 Pages

SKU # ROAL18576018

Description

Prefilled Syringes Market

Prefilled Syringes Market (7th Edition), Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic Prefilled Syringes), Therapeutic Area (Therapeutic Syringes - Blood Disorders, Infectious Diseases, Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Respiratory Disorders, Neurological Disorders, Metabolic Disorders, Ophthalmic Disorders, Orthopedic Disorders and Others), Type of Molecule (Therapeutic Syringes - Proteins, Antibodies, Peptides, Small Molecules, Vaccines and Cell Therapies), Type of Barrel Material (Glass Syringes and Plastic Syringes), Number of Barrel Chamber (Single Chamber Syringes and Dual Chamber Syringes), Type of Needle System (Staked Needle Syringes and Luer Syringes), Usability of Syringe (Disposable Syringes and Reusable Syringes), Type of Syringe (Conventional Syringes and Safety Syringes), Type of Packaging (Bulk Syringes and Nested Syringes) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America)The prefilled syringes market is expected to reach USD 3 billion by 2024 anticipated to grow at a CAGR of 4.6% during the forecast period 2024-2035.

The prevalence of chronic disorders such as autoimmune conditions (e.g., rheumatoid arthritis), cardiovascular diseases, diabetes, and oncological disorders has surged globally in recent years. In the United States, nearly 133 million individuals were estimated to be affected by one or more chronic disorders in 2022, with this number anticipated to reach 170 million by 2030. According to a recent study by the US Centers for Disease Control (CDC), the annual economic burden associated with chronic disorders in the US stands at USD 4.1 trillion. A significant portion of these costs arise from the frequent requirement for medication, leading to regular hospital visits. Moreover, patient hesitance towards receiving injections in clinical settings due to privacy concerns or discomfort presents an additional challenge, impacting patient adherence to treatment regimens.

To mitigate these challenges, various self-administration devices like autoinjectors, prefilled syringes, and pen injectors have been developed. Prefilled syringes, in particular, have gained prominence, especially in emergency situations such as anaphylactic shock and rheumatoid arthritis treatment. These syringes come pre-loaded with precise doses of parenteral medication, eliminating the need for manual filling. They offer benefits such as convenience, dose accuracy, reduced risk of contamination, and minimal drug wastage. By reducing the frequency of patient visits to healthcare providers, prefilled syringes contribute to lowering global healthcare expenditures. Currently, various types of prefilled syringes are available, including dual-chamber prefilled syringes, flush syringes, and safety syringes equipped with mechanisms to prevent needlestick injuries. With the growing adoption of self-administering parenteral devices, ongoing technological advancements, and increasing preference for home healthcare services, the global prefilled syringes market is poised for significant growth in the foreseeable future.Report Coverage

The report comprehensively examines the prefilled syringe market based on purpose of syringe, therapeutic area, type of molecule, type of barrel material, number of barrel chamber, type of needle system, usability of syringe, type of syringe, type of packaging and key geographical regions.

It thoroughly analyzes market influences such as drivers, restraints, opportunities, and challenges, while evaluating competitive landscapes for top players. Forecasts are provided for segment revenues across major regions.

This chapter provides an extensive overview of prefilled syringes, covering their components, historical evolution, and associated benefits. It also examines various types of prefilled syringes categorized by factors such as barrel fabrication material, needle system, and packaging method. The manufacturing process for prefilled syringes is detailed, along with future growth prospects for the industry.

A comprehensive assessment of the current prefilled syringes market landscape is conducted, considering parameters such as barrel fabrication material, needle system type, and syringe volume. Additionally, the chapter offers an in-depth analysis of prefilled syringe manufacturers, including establishment details, company size, headquarters location, manufacturing facility location, and identification of key players based on production volume.

Detailed evaluation of prefilled syringe manufacturers' competitiveness, considering factors such as product development stage, barrel chamber count, syringe volume availability, and types of needle systems offered.

Elaborate profiles of notable prefilled syringe manufacturers located across North America, Europe, and the Asia Pacific region are presented, along with profiles of other prominent players in the industry. Each profile includes company overview details such as establishment year, headquarters location, employee count, and leadership team information. Financial data, if available, is also provided alongside details of the manufacturer's prefilled syringe portfolio, recent advancements, and future outlook.

The chapter addresses concerns regarding needlestick injuries and outlines safety measures implemented in prefilled syringes, including regional and global legislation efforts. It highlights companies involved in developing and manufacturing safety solutions for prefilled syringes.

A comprehensive summary of regulatory guidelines set by major regulatory bodies for prefilled syringe approval across different countries and regions.

An in-depth analysis of combination products available or under evaluation in prefilled syringe form, focusing on injectable drugs and vaccines. This analysis includes approved drugs categorized by drug molecule type, approval year, administration route, and therapeutic area. Additionally, it covers products in clinical stages, considering parameters such as drug molecule type, development phase, administration route, and therapeutic focus, along with insights into the involved drug developers.

A thorough examination of prevalent therapeutic indications commonly targeted in medical treatment, with detailed information on approved or marketed injectable drug products used across various therapeutic areas, along with insights into biosimilar availability for these drugs.

A comprehensive overview of marketed drugs or therapies expected to be accessible in prefilled syringe format soon, based on parameters such as historical sales data, drug molecule type, therapeutic area, administration route, and existing dosage forms.

An assessment of prefilled syringe combination product-related initiatives by major pharmaceutical companies, considering factors such as revenue generation in 2022, number of combination products, target therapeutic areas, and drug molecule types.

An analysis of partnerships established in the prefilled syringe sector, covering parameters such as initiative year, type, geographical distribution, and key players involved.

An examination of patents related to prefilled syringes filed or granted since 2019, considering aspects such as patent type, publication year, applicant type, geographical location, CPC symbols, and leading players in terms of patent filings. Additionally, the chapter includes patent benchmarking and valuation analysis focusing on patents with high citation counts, along with identification of key opinion leaders in the prefilled syringe domain based on roles, affiliations, indications, and locations.

Detailed information on specialty syringes including prefilled flush syringes, diluent systems, and syringes with contrast agents, along with available products in the market and their respective benefits.

Recent technological advancements in prefilled syringe design and manufacturing are discussed, focusing on innovations enabling lyophilized drug marketing in dual-chambered syringes, as well as advancements in lubrication and sterilization technologies.

An analysis of factors expected to drive growth in the prefilled syringes market, including the rise in chronic diseases, preference for self-medication, evolving patient preferences, adoption of biologics and biosimilars, pharmaceutical strategies, needlestick injury prevention initiatives, and potential applications of prefilled syringes.

Industry trends, opportunities, and challenges are discussed under a SWOT analysis, highlighting their potential impact on the prefilled syringes market evolution, accompanied by a Harvey ball analysis illustrating the relative significance of each SWOT parameter on industry dynamics.

Key Market Companies

Becton Dickinson and Company

Credence MedSystems

Gerresheimer

J.O.Pharma

Medefil

MedXL

Mitsubishi Gas Chemical

Nipro PharmaPackaging

Novartis

Pfizer

SCHOTT

Shandong Pharmaceutical Glass

Shandong Weigao

Shin Yan Sheno Precision Industrial

Stevanato

Taisei Kako

Vetter Pharma

West Pharmaceutical

1. Preface: 1.1. Prefilled Syringes Market; 1.2. Market Share Insights; 1.2.1 Market Segmentation Overview; 1.3. Key Market Insights; 1.4. Report Coverage; 1.5. Key Questions Answered; 1.6. Chapter Outlines
2. Research Methodology: 2.1. Chapter Overview; 2.2. Research Assumptions; 2.3. Project Methodology; 2.4. Forecast Methodology; 2.5. Robust Quality Control; 2.6. Key Market Segmentations; 2.7. Key Considerations; 2.7.1. Demographics; 2.7.2. Economic Factors; 2.7.3. Government Regulations; 2.7.4. Supply Chain; 2.7.5. Covid Impact / Related Factors; 2.7.6. Market Access; 2.7.7. Healthcare Policies; 2.7.8. Industry Consolidation
3. Economic And Other Project Specific Considerations: 3.1. Chapter Overview; 3.2. Market Dynamics; 3.2.1. Time Period; 3.2.1.1. Historical Trends; 3.2.1.2. Current And Forecasted Estimates; 3.2.2. Currency Coverage; 3.2.2.1. Overview Of Major Currencies Affecting The Market; 3.2.2.2. Impact Of Currency Fluctuations On The Industry; 3.2.3. Foreign Exchange Impact; 3.2.3.1. Evaluation Of Foreign Exchange Rates And Their Impact On Market; 3.2.3.2. Strategies For Mitigating Foreign Exchange Risk; 3.2.4. Recession; 3.2.4.1. Historical Analysis Of Past Recessions And Lessons Learnt; 3.2.4.2. Assessment Of Current Economic Conditions And Potential Impact On The Market; 3.2.5. Inflation; 3.2.5.1. Measurement And Analysis Of Inflationary Pressures In The Economy; 3.2.5.2. Potential Impact Of Inflation On The Market Evolution
4. Executive Summary
5. Introduction: 5.1. Chapter Overview; 5.2. History Of Prefilled Syringes; 5.3. Benefits Of Prefilled Syringes Over Traditional Injectable Devices; 5.3.1. Benefits Of Prefilled Syringes For Healthcare Professionals And End Users; 5.3.2. Benefits Of Prefilled Syringes For Manufacturers; 5.3.3. Transition From Existing Dosing Forms To Prefilled Syringes; 5.4. Prefilled Syringe Components; 5.5. Classification Of Prefilled Syringes; 5.5.1. Classification Based On Barrel Fabrication Material; 5.5.1.1. Glass Barrel Prefilled Syringes; 5.5.1.1.1. Limitations Of Glass Barrel Prefilled Syringes; 5.5.1.1.2. Addressing The Limitations Of Glass Barrel Prefilled Syringes; 5.5.1.2. Plastic Barrel Prefilled Syringes; 5.5.1.2.1. Limitations Of Plastic Barrel Prefilled Syringes; 5.5.1.2.2. Addressing The Limitations Of Plastic Barrel Prefilled Syringes; 5.5.1.2.3. Factors Likely To Drive The Use Of Plastic Prefilled Syringes; 5.5.2. Classification Based On Number Of Chambers In The Barrel; 5.5.3. Classification Based On Type Of Needle; 5.5.4. Classification Based On Type Of Packaging; 5.6. Critical Attributes Of Prefilled Syringe Design; 5.7. Key Manufacturing Steps For Prefilled Syringes; 5.7.1. Production Of Barrels; 5.7.1.1. Glass Barrels; 5.7.1.2. Plastic Barrels; 5.7.2. Production Of Syringes; 5.7.3. Barrel Siliconization; 5.7.4. Syringe Sterilization; 5.7.5. Validation Of Sterilization; 5.7.6. Syringe Filling; 5.7.7. Syringe Testing; 5.8. Future Perspectives
6. Prefilled Syringes: Market Overview: 6.1. Chapter Overview; 6.2. Prefilled Syringes: Overall Market Landscape; 6.2.1. Analysis By Type Of Barrel Fabrication Material; 6.2.2. Analysis By Number Of Barrel Chambers; 6.2.3. Analysis By Type Of Needle System; 6.2.4. Analysis By Volume Of Syringe; 6.3. Prefilled Syringes Manufacturers: Overall Market Landscape; 6.3.1. Analysis By Year Of Establishment; 6.3.2. Analysis By Company Size; 6.3.3. Analysis By Location Of Headquarters; 6.3.4. Analysis By Company Size And Location Of Headquarters; 6.3.5. Analysis By Location Of Manufacturing Facilities; 6.3.6. Most Active Players: Analysis By Number Of Prefilled Syringes
7. Product Competitiveness Analysis: 7.1. Chapter Overview; 7.2. Assumptions And Key Parameters; 7.3. Methodology; 7.4. Product Competitiveness Analysis: Prefilled Syringes; 7.4.1. Glass Barrel Prefilled Syringes; 7.4.2. Plastic Barrel Prefilled Syringes
8. Company Profiles: Prefilled Syringe Manufacturers In North America: 8.1. Chapter Overview; 8.2. Detailed Company Profiles Of Leading Prefilled Syringe Manufacturers; 8.3.1 Becton, Dickinson And Company; 8.3.1.1. Company Overview; 8.3.1.2. Financial Information; 8.3.1.3. Becton, Dickinson And Company Prefilled Syringes Portfolio; 8.3.1.4. Recent Developments And Future Outlook; 8.3.2. Medefil; 8.3.2.1. Company Overview; 8.3.2.2. Medefil Prefilled Syringes Portfolio; 8.3.2.3. Recent Developments And Future Outlook; 8.3.3. West Pharmaceutical; 8.3.3.1. Company Overview; 8.3.3.2. Financial Information; 8.3.3.2. West Pharmaceutical Prefilled Syringes Portfolio; 8.3.3.3. Recent Developments And Future Outlook; 8.4. Short Profiles Of Other Prominent Prefilled Syringe Manufacturers; 8.4.1. Medline; 8.4.1.1. Company Overview; 8.4.1.2. Prefilled Syringes Portfolio; 8.4.2. Medxl; 8.4.2.1. Company Overview; 8.4.2.2. Prefilled Syringes Portfolio; 8.4.3 Pfizer; 8.4.3.1. Company Overview; 8.4.3.2. Prefilled Syringes Portfolio
9. Company Profiles: Prefilled Syringe Manufacturers In Europe: 9.1. Chapter Overview; 9.2. Detailed Company Profiles Of Leading Prefilled Syringe Manufacturers; 9.3.1. Gerresheimer; 9.3.1.1. Company Overview; 9.3.1.2. Financial Information; 9.3.1.3. Gerresheimer Prefilled Syringes Portfolio; 9.3.1.4. Recent Developments And Future Outlook; 9.3.2 Schott; 9.3.2.1. Company Overview; 9.3.2.2. Financial Information; 9.3.2.3. Schott Prefilled Syringes Portfolio; 9.3.2.4. Recent Developments And Future Outlook; 9.3.3. Stevanato; 9.3.3.1. Company Overview; 9.3.2.2. Financial Information; 9.3.3.3. Stevanato Prefilled Syringes Portfolio; 9.3.3.4. Recent Developments And Future Outlook; 9.4. Short Profiles Of Other Prominent Prefilled Syringe Manufacturers; 9.4.1 B. Braun; 9.4.1.1. Company Overview; 9.4.1.2. Prefilled Syringes Portfolio; 9.4.2. Nipro Europe; 9.4.2.1. Company Overview; 9.4.2.2. Prefilled Syringes Portfolio; 9.4.3. Vetter Pharma; 9.4.3.1. Company Overview; 9.4.3.2. Prefilled Syringes Portfolio
10. Company Profiles: Prefilled Syringe Manufacturers In Asia-pacific: 10.1. Chapter Overview; 10.2. Detailed Company Profiles Of Leading Prefilled Syringe Manufacturers; 10.2.1 Shandong Zibo Minkang Pharmaceutical Packing; 10.2.1.1. Company Overview; 10.2.1.2. Shandong Zibo Minkang Pharmaceutical Packing Prefilled Syringes Portfolio; 10.2.1.3. Recent Developments And Future Outlook; 10.2.2. Shin Yan Sheno Precision Industrial; 10.2.2.1. Company Overview; 10.2.2.2. Taisei Kako Prefilled Syringes Portfolio; 10.2.2.3. Recent Developments And Future Outlook; 10.2.3. Taisei Kako; 10.2.3.1. Company Overview; 10.2.3.2. Taisei Kako Prefilled Syringes Portfolio; 10.2.3.3. Recent Developments And Future Outlook; 10.3. Short Profiles Of Other Prominent Prefilled Syringe Manufacturers; 10.3.1 J.O.Pharma; 10.3.1.1. Company Overview; 10.3.1.2. Prefilled Syringes Portfolio; 10.3.2. Shandong Pharmaceutical Glass; 10.3.2.1. Company Overview; 10.3.2.2. Prefilled Syringes Portfolio; 10.3.3. Shandong Weigao Group Medical Polymer; 10.3.3.1. Company Overview; 10.3.3.2. Prefilled Syringes Portfolio
11. Needlestick Injuries: 11.1. Chapter Overview; 11.2. Incidence And Associated Financial Burden; 11.3. Government Legislations For Prevention Of Needlestick Injuries; 11.4. Safety Mechanisms Used In Modern Prefilled Syringes; 11.4.1. Safety Systems: Add-on Safety Device Manufacturers; 11.4.1.1. Becton Dickinson And Company; 11.4.1.2. Nemera; 11.4.1.3. Nipro Pharmapackagin; 11.4.1.4. Terumo; 11.4.1.5. West Pharmaceutical; 11.4.2. Safety Systems: Integrated Safety Device Manufacturers; 11.4.2.1. Gerresheimer; 11.4.2.2. Injecto; 11.4.2.3. Medicalchain International; 11.4.2.4. Stevanato; 11.4.2.5. Owen Mumford; 11.4.2.6. Shl Group; 11.4.2.7. Taisei Kako
12. Regulatory Landscape For Prefilled Syringes: 12.1. Chapter Overview; 12.2. Regulatory Approval Of Combination Products In North America; 12.2.1. Regulatory Approval Of Combination Products In The Us; 12.2.1.1. Overview; 12.2.1.2. Historical Background; 12.1.1.3. Role Of Regulatory Bodies In Product Approval; 12.1.1.4. Regulatory Approval Of Prefilled Syringes; 12.1.1.4.1. Reimbursement Landscape In The Us; 12.1.1.4.2. Payer Mix; 12.1.1.4.3.. Reimbursement Process In The Us; 12.2.2. Regulatory Approval Of Combination Products In Canada; 12.2.2.1. Overview; 12.2.2.2. Role Of Regulatory Bodies In Product Approval; 12.2.2.3. Regulatory Approval For Prefilled Syringes; 12.2.2.3.1. Reimbursement Landscape In Canada; 12.2.2.3.2. Payer Mix; 12.2.2.3.3. Reimbursement Process In Canada; 12.3. Regulatory Approval Of Combination Products In Europe; 12.3.1. Overview; 12.3.2. Role Of Regulatory Bodies In Product Approval; 12.3.3. Regulatory Approval Of Prefilled Syringes; 12.3.4. Regulatory Approval Of Combination Products In The Uk; 12.3.4.1. Reimbursement Landscape In The Uk; 12.3.4.2. Payer Mix; 12.3.4.3. Reimbursement Process In The Uk; 12.3.5. Regulatory Approval Of Combination Products In France; 12.3.5.1. Reimbursement Landscape In France; 12.3.5.2. Payer Mix; 12.3.5.3. Reimbursement Process In France; 12.3.6. Regulatory Approval Of Combination Products In Spain; 12.3.6.1. Reimbursement Landscape In Spain; 12.3.6.2. Payer Mix; 12.3.6.3. Reimbursement Process In Spain; 12.3.7. Regulatory Approval Of Combination Products In Spain; 12.3.7.1. Reimbursement Landscape In Germany; 12.3.7.2. Payer Mix; 12.3.7.3. Reimbursement Process In Germany; 12.3.8. Regulatory Approval Of Combination Products In Italy; 12.3.8.1. Reimbursement Landscape In Italy; 12.3.8.2. Payer Mix; 12.3.8.3. Reimbursement Process In Italy; 12.4. Regulatory Approval Of Combination Products In Asia-pacific; 12.4.1. Regulatory Approval Of Combination Products In Japan; 12.4.1.1 Overview; 12.4.1.2 Role Of Regulatory Bodies In Product Approval; 12.4.1.3. Regulatory Approval Of Prefilled Syringes; 12.4.1.3.1. Reimbursement Landscape In Japan; 12.4.1.3.2. Payer Mix; 12.4.1.3.3. Reimbursement Process In Japan; 12.4.2. Regulatory Approval Of Combination Products In China; 12.4.2.1. Overview; 12.4.2.2. Role Of Regulatory Bodies In Product Approval; 12.4.2.3. Regulatory Approval For Prefilled Syringes; 12.4.2.3.1. Reimbursement Landscape In China; 12.4.2.3.2. Payer Mix; 12.4.2.3.3. Reimbursement Process In China; 12.4.3. Regulatory Approval Of Combination Products In India; 12.4.3.1. Overview; 12.4.3.2. Role Of Regulatory Bodies In Product Approval; 12.4.3.3. Regulatory Approval Of Prefilled Syringes; 12.4.3.3.1. Reimbursement Landscape In India; 12.4.3.3.2. Payer Mix; 12.4.4. Regulatory Approval Of Combination Products In South Korea; 12.4.4.1. Overview; 12.4.4.2. Role Of Regulatory Bodies In Product Approval; 12.4.4.3. Regulatory Approval Of Prefilled Syringes; 12.4.4.3.1. Reimbursement Landscape In South Korea; 12.4.4.3.2. Payer Mix; 12.4.4.3.3. Reimbursement Process In South Korea; 12.4.5. Regulatory Approval Of Combination Products In Saudi Arabia; 12.4.5.1. Overview; 12.4.5.2. Role Of Regulatory Bodies In Product Approval; 12.4.5.3. Regulatory Approval Of Prefilled Syringes; 12.4.5.3.1. Reimbursement Landscape In Saudi Arabia; 12.4.5.3.2. Payer Mix; 12.4.5.3.3. Reimbursement Process In Saudi Arabia; 12.4.6. Regulatory Approval Of Combination Products In United Arab Emirates; 12.4.6.1. Overview; 12.4.6.2. Role Of Regulatory Bodies In Product Approval; 12.4.6.3. Regulatory Approval Of Prefilled Syringes; 12.4.6.3.1. Reimbursement Landscape In United Arab Emirates; 12.4.6.3.2. Payer Mix; 12.4.6.3.3. Reimbursement Process In United Arab Emirates; 12.5. Regulatory Approval Of Combination Products In Rest Of The World; 12.5.1. Regulatory Approval Of Combination Products In Brazil; 12.5.1.1 Overview; 12.5.1.2 Role Of Regulatory Bodies In Product Approval; 12.5.1.3. Regulatory Approval Of Prefilled Syringes; 12.5.1.3.1. Reimbursement Landscape In Brazil; 12.5.1.3.2. Payer Mix; 12.5.1.3.3. Reimbursement Process In Brazil; 12.5.2. Regulatory Approval Of Combination Products In Australia; 12.5.2.1 Overview; 12.5.2.2 Role Of Regulatory Bodies In Product Approval; 12.5.2.3. Regulatory Approval Of Prefilled Syringes; 12.5.2.3.1. Reimbursement Landscape In Australia; 12.5.2.3.2. Payer Mix; 12.5.2.3.3. Reimbursement Process In Australia
13. Prefilled Syringe Combination Products: 13.1. Chapter Overview; 13.2. Prefilled Syringe Combination Products: Approved Drugs; 13.2.1. Analysis By Type Of Drug Molecule; 13.2.2. Analysis By Product Approval; 13.2.3. Analysis By Route Of Administration; 13.2.4. Analysis By Target Therapeutic Area; 13.2.5. Analysis By Region Of Product Analysis; 13.2.6. Analysis By Other Approved Primary Packaging Systems; 13.3. Prefilled Syringe Combination Products: Clinical Stage Drugs; 13.3.1. Analysis By Type Of Drug Molecule; 13.3.2. Analysis By Phase Of Development; 13.3.3. Analysis By Route Of Administration; 13.3.4. Analysis By Target Therapeutic Area; 13.4. Prefilled Syringe Combination Products: Developers Landscape; 13.4.1. Analysis By Year Of Establishment; 13.4.2. Analysis By Company Size; 13.4.3. Analysis By Location Of Headquarters; 13.5. Leading Drugs In Prefilled Syringe Format; 13.6. Other Drugs Available In Prefilled Syringe Format; 13.7. Most Popular Drug Available In Prefilled Syringe Format: Humira (Adalimumab), Abbvie / Eisai; 13.7.1. Target Indications And Available Dosage Forms; 13.7.2. Shift From Vials To Prefilled Syringes; 13.7.3. Humira Annual Sales, Fy 2010-fy 2022
14. Key Therapeutic Areas: 14.1. Chapter Overview; 14.2. Autoimmune Disorders; 14.2.1. Approved Drugs; 14.2.2. Key Developments; 14.2.3. Upcoming / Commercialized Biosimilars For Autoimmune Drugs; 14.3. Infectious Diseases; 14.3.1. Approved Drugs; 14.3.2. Key Developments; 14.4. Neurological Disorders; 14.4.1. Approved Drugs; 14.4.2. Key Developments
15. Prefilled Syringes: Likely Drug Candidates Analysis: 15.1. Chapter Overview; 15.2. Likely Drug Candidates; 15.2.1. Assumption And Key Parameters; 15.2.2. Methodology; 15.2.3. Most Likely Candidates For Delivery Via Prefilled Syringes; 15.2.4. Likely Candidates For Delivery Via Prefilled Syringes; 15.2.5. Less Likely Candidates For Delivery Via Prefilled Syringe
16. Combination Products: Big Pharma Activity: 16.1. Chapter Overview; 16.2. Methodology; 16.3. Combination Products: Big Pharma Activity; 16.3.1. Analysis By Target Therapeutic Area; 16.3.1.1. Autoimmune Disorders; 16.3.1.2. Infectious Diseases; 16.3.1.3. Neurological Disorders; 16.3.1.4. Blood Disorders; 16.3.1.5. Oncological Disorders; 16.3.2. Analysis By Type Of Molecule; 16.3.2.1. Antibodies; 16.3.2.2. Vaccines; 16.3.2.3. Proteins; 16.3.2.4. Peptides; 16.3.2.5. Small Molecules; 16.3.2.6. Other Biologics
17. Recent Developments: 17.1. Chapter Overview; 17.2. Prefilled Syringes: Recent Developments; 17.3. Analysis By Year Of Initiative; 17.4. Analysis By Type Of Initiative; 17.5. Analysis By Year And Type Of Initiative; 17.5.1. Analysis By Location Of Expansion; 17.5.2. Analysis By Type Of Expansion; 17.5.3 Analysis By Type Of Partnership; 17.6. Analysis By Geography; 17.7. Most Active Players: Distribution By Number Of Recent Initiatives; 17.8. Analysis Of Player By Type Of Initiatives
18. Patent Analysis: 18.1. Chapter Overview; 18.2. Scope And Methodology; 18.3. Prefilled Syringes: Patent Analysis; 18.3.1. Analysis By Patent Publication Year; 18.3.2. Analysis By Type Of Patent And Publication Year; 18.3.3. Analysis By Patent Application Year; 18.3.4. Analysis By Patent Jurisdiction; 18.3.5. Analysis By Cpc Symbols; 18.3.6. Analysis By Type Of Applicant; 18.3.7. Leading Players: Analysis By Number Of Patents; 18.3.8. Leading Individual Assignees: Analysis By Number Of Patents; 18.4. Prefilled Syringes: Patent Benchmarking Analysis; 18.4.1. Analysis By Patent Characteristics; 18.5. Prefilled Syringes: Patent Valuation Analysis; 18.6. Leading Patents By Number Of Citations
19. Kol Analysis: 19.1. Chapter Overview; 19.2. Assumption And Key Parameters; 19.3. Methodology; 19.4. Prefilled Syringes: Key Opinion Leaders; 19.4.1. Analysis By Role Of Kol; 19.4.2. Analysis By Type Of Sponsor Organization; 19.4.3. Analysis By Affiliated Organization; 19.4.4. Analysis By Target Disease Indication; 19.4.5. Analysis By Geographical Location; 19.4.6. Most Prominent Kols: Analysis By Activeness, Expertise And Strength Of Kol; 19.4.7. Most Prominent Kols: Analysis By Ra Score
20. Specialty Prefilled Syringes: 20.1. Chapter Overview; 20.2. Prefilled Flush Syringes; 20.2.1. Overview; 20.2.2. Advantages Of Prefilled Flush Syringes; 20.2.3. Prefilled Flush Syringes Available In The Market; 20.3. Prefilled Diluent Syringes; 20.3.1. Overview; 20.3.2. Advantages Of Prefilled Diluent Syringes; 20.3.3. Lyophilized Drugs Available In Prefilled Diluent Syringes; 20.4. Contrast Agent Prefilled Syringes; 20.4.1. Overview; 20.4.2. Advantages Of Using Prefilled Syringes For Contrast Agents; 20.4.3. Contrast Agents Available In Prefilled Syringes
21. Technological Advances Related To Prefilled Syringes: 21.1. Chapter Overview; 21.2. Prefilled Syringes For Lyophilized Drugs; 21.2.1. Prefilled Diluent Syringes; 21.2.2. Prefilled Dual-chamber Syringes; 21.3. Multilayer Plastic Prefilled Syringes With Oxygen Barrier; 21.4. Prefilled Syringes With Low Risk Of Particle Formation; 21.5. Advanced Lubrication Technology For Prefilled Syringes; 21.6. Advances In Terminal Sterilization Of Prefilled Syringes; 21.7. Prefilled Syringe Usage Aids For Patients And Healthcare Providers; 21.8. Additional Advancements
22. Key Growth Drivers: 22.1. Chapter Overview; 22.2. Rising Incidence Of Chronic Diseases; 22.3. Growing Preference For Self-injection; 22.4. Evolving Patient Demographics; 22.5. Growth Of Biologics And Biosimilars Market; 22.6. Changing Pharmaceutical Practices; 22.7. Increasing Focus On Prevention Of Needlestick Injuries; 22.8. Prefilled Syringes In Autoinjectors And Pen Injectors
23. Swot Analysis: 23.1. Chapter Overview; 23.2. Strengths; 23.2.1. Ease Of Use; 23.2.2. Ability To Reduce / Eliminate Medication Errors; 23.2.3. Reducing The Risk Of Accidental Transmission Of Blood-borne Pathogens; 23.2.4. Economic Advantages; 23.2.5. Drug Life Cycle Management; 23.3. Weaknesses; 23.3.1. Manufacturing Complexities; 23.3.2. High Packaging And Transportation Costs; 23.3.3. Product Stability And Quality Related Issues; 23.3.4. Challenges Associated With Drug Filing; 23.4. Opportunities; 23.4.1. Rich And Growing Pipeline Of Biologics And Biosimilars; 23.4.2. Growing Preference For Self-injecting; 23.4.3. Application In Advanced Drug Delivery Devices; 23.4.4. Innovation In Design And Technical Advancement; 23.4.5. Rising Popularity Across The Globe; 23.4.6. Widespread Use In Vaccination Programs; 23.5. Threats; 23.5.1. Material Compatibility Issues; 23.5.2. Availability Of Alternative Drug Delivery Devices; 23.5.3. Concern Related To Numerous Product Recalls In Past; 23.6. Concluding Remarks
24. Global Prefilled Syringes Market: 24.1. Chapter Overview; 24.2. Assumptions And Methodology; 24.3. Global Prefilled Syringes Market, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 24.3.1. Scenario Analysis; 24.4. Key Market Segmentations
25. Prefilled Syringes Market, By Purpose Of Syringe: 25.1. Chapter Overview; 25.2. Key Assumptions And Methodology; 25.3. Prefilled Syringes Market: Distribution By Purpose Of Syringe, 2018, 2023 And 2035; 25.3.1. Specialty Prefilled Syringe: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 25.3.2. Therapeutic Prefilled Syringe: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 25.3.3. Cosmetic Prefilled Syringe: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 25.4. Data Triangulation And Validation
26. Prefilled Syringes Market, By Type Of Molecule: 26.1. Chapter Overview; 26.2. Key Assumptions And Methodology; 26.3. Prefilled Syringes Market: Distribution By Type Of Molecule, 2018, 2023 And 2035; 26.3.1. Prefilled Syringes Market For Proteins: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 26.3.2. Prefilled Syringes Market For Antibodies: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 26.3.3. Prefilled Syringes Market For Peptides: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 26.3.4. Prefilled Syringes Market For Small Molecules: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 26.3.5. Prefilled Syringes Market For Vaccines: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 26.3.6. Prefilled Syringes Market For Cell Therapies: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 26.4. Data Triangulation And Validation
27. Prefilled Syringes Market, By Therapeutic Area: 27.1. Chapter Overview; 27.2. Key Assumptions And Methodology; 27.3. Prefilled Syringes Market: Distribution By Therapeutic Area, 2018, 2023 And 2035; 27.3.1. Prefilled Syringes Market For Blood Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.2. Prefilled Syringes Market For Infectious Diseases: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.3. Prefilled Syringes Market For Autoimmune Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.4. Prefilled Syringes Market For Oncological Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.5. Prefilled Syringes Market For Cardiovascular Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.6. Prefilled Syringes Market For Respiratory Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.7. Prefilled Syringes Market For Neurological Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.8. Prefilled Syringes Market For Metabolic Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.9. Prefilled Syringes Market For Ophthalmic Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.10. Prefilled Syringes Market For Orthopedic Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.3.11 Prefilled Syringes Market For Other Disorders: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 27.4. Data Triangulation And Validation
28. Prefilled Syringes Market, By Type Of Barrel Material: 28.1. Chapter Overview; 28.2. Key Assumptions And Methodology; 28.3. Prefilled Syringes Market: Distribution By Type Of Barrel Material, 2018, 2023 And 2035; 28.3.1. Glass Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 28.3.2. Plastic Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 28.4. Data Triangulation And Validation
29. Prefilled Syringes Market, By Number Of Chamber: 29.1. Chapter Overview; 29.2. Key Assumptions And Methodology; 29.3. Prefilled Syringes Market: Distribution By Number Of Chamber, 2018, 2023 And 2035; 29.3.1. Single Chamber Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 29.3.2. Dual Chamber Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 29.4. Data Triangulation And Validation
30. Prefilled Syringes Market, By Type Of Needle System: 30.1. Chapter Overview; 30.2. Key Assumptions And Methodology; 30.3. Prefilled Syringes Market: Distribution By Type Of Needle System, 2018, 2023 And 2035; 30.3.1. Staked Needle Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 30.3.2. Luer Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 30.4. Data Triangulation And Validation
31. Prefilled Syringes Market, By Usability Of Syringe: 31.1. Chapter Overview; 31.2. Key Assumptions And Methodology; 31.3. Prefilled Syringes Market: Distribution By Usability Of Syringe, 2018, 2023 And 2035; 31.3.1. Disposable Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 31.3.2. Reusable Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 31.4. Data Triangulation And Validation
32. Prefilled Syringes Market, By Type Of Syringe: 32.1. Chapter Overview; 32.2. Key Assumptions And Methodology; 32.3. Prefilled Syringes Market: Distribution By Type Of Syringe, 2018, 2023 And 2035; 32.3.1. Conventional Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 32.3.1. Safety Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 32.4. Data Triangulation And Validation
33. Prefilled Syringes Market, By Type Of Packaging: 33.1. Chapter Overview; 33.2. Key Assumptions And Methodology; 33.3. Prefilled Syringes Market: Distribution By Type Of Packaging, 2018, 2023 And 2035; 33.3.1. Bulk Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 33.3.2. Nested Prefilled Syringes: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 33.4. Data Triangulation And Validation
34. Prefilled Syringes Market, By Key Geographical Regions: 34.1. Chapter Overview; 34.2. Key Assumptions And Methodology; 34.3. Prefilled Syringes Market: Distribution By Key Geographical Region, 2018, 2023 And 2035; 34.3.1 Prefilled Syringes Market In North America: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 34.3.2. Prefilled Syringes Market In Europe: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 34.3.3. Prefilled Syringes Market In Asia-pacific: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 34.3.4. Prefilled Syringes Market In Middle East And South Africa: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 34.3.5 Prefilled Syringes Market In Latin America: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 34.4. Data Triangulation And Validation
35. Prefilled Syringes Market, For Blood Disorders: 35.1. Chapter Overview; 35.2. Key Assumptions And Methodology; 35.3. Prefilled Syringes Market For Blood Disorders: Distribution By Type Of Molecule; 35.3.1. Proteins Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.3.2. Small Molecules Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.4. Prefilled Syringes Market For Blood Disorders: Distribution By Type Of Barrel Material; 35.4.1. Glass Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.4.2. Plastic Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.5. Prefilled Syringes Market For Blood Disorders: Distribution By Number Of Chamber; 35.5.1. Single Chamber Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.5.2. Dual Chamber Prefilled Syringes, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.6. Prefilled Syringes Market For Blood Disorders: Distribution By Type Of Needle System; 35.6.1. Staked Needle Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.6.2. Luer Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.7. Prefilled Syringes Market For Blood Disorders: Distribution By Usability Of Syringe; 35.7.1. Disposable Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.7.2. Reusable Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.8. Prefilled Syringes Market For Blood Disorders: Distribution By Type Of Syringe; 35.8.1. Conventional Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.8.2. Safety Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.9. Prefilled Syringes Market For Blood Disorders: Distribution By Type Of Packaging; 35.9.1. Bulk Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 35.9.2. Nested Prefilled Syringes Market For Blood Disorders, Historical Trends (2018- 2022) And Forecasted Estimates (2023-2035)

Pricing

Currency Rates

PDF Email from Publisher – One User License $4,799
PDF Email from Publisher – Consulting Company Team License $8,999
PDF Email from Publisher – Department License $10,599
PDF Email from Publisher – Global Site License for One Company $17,999

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now